Phase 3Completed
A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia
A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin Versus Pitavastatin/Fenofibrate in Complex-dyslipidemia Patients
- Sponsor
- Hanlim Pharm. Co., Ltd. (Industry)
- Enrolment
- 347 enrolled
- Conditions
- Complex-dyslipidemia
- Interventions
- HL-PIF cap.160/2mg + Placebo; Livalo tab. 2mg + Placebo
- Ages
- adults, older adults
- Registry
- NCT03618797
Full record on ClinicalTrials.gov
From the registry
The purpose of this study is to evaluate the efficacy and safety of Pitavastatin versus Pitavastatin/Fenofibrate in complex-dyslipidemia patients.
Primary outcomes
- The mean percentage change of Non-HDL Cholesterol
History
Registered
Study completion
Primary completion
Started